Pharmacists in Westover, WV Accepting Medicare
9 Pharmacists found. Showing 1 - 9
 Chandler Haines Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Fairmont Rd, Westover, WV 26501 Phone: 304-296-2547 |
Christopher Mark Hale, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Fairmont Rd, Westover, WV 26501 Phone: 304-296-2547 |
Dr. Garrett M White, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Fairmont Rd, Westover, WV 26501 Phone: 304-296-2547 |
 Dr. Kari E Cooper, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Fairmont Rd, Westover, WV 26508 Phone: 304-296-2547 |
Dr. Nathan Dale Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Fairmont Rd, Westover, WV 26501 Phone: 304-295-2547 |
Megan Collins Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Fairmont Rd, Westover, WV 26501 Phone: 304-296-2547 |
Eric Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Fairmont Rd, Westover, WV 26501 Phone: 714-414-8779 |
Jana R Hennessey Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Fairmont Rd, Westover, WV 26501 Phone: 304-296-2547 |
Aaron Hanzes Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Fairmont Rd, Westover, WV 26501 Phone: 304-296-2547 |
News Archive
Minister for seniors at famed church confronts ageism and the shame it brings
Later life is a time of reassessment and reflection. What sense do we make of the lives we have lived? How do we come to terms with illness and death? What do we want to give to others as we grow older?
Majority of patients with ulcerative colitis eager to undergo fecal microbiota transplantation
The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.
Otsuka, Bristol-Myers Squibb announce six-year data from SPRYCEL Phase 3 trial on CP-CML
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
Global food crisis is not imminent, but food commodities markets need regulation, FAO official says
A global food crisis does not appear to be on the horizon despite recent food price rises, but steps must be taken to regulate volatile food commodities markets, Hafez Ghanem, a top official at the U.N. Food and Agriculture Organization, said on Tuesday, the Associated Press reports.
› Verified 6 days ago
Pharmacists
Dentists
Counselors
Clinical Social Workers
Occupational Therapists
Psychologists